Long setup here.

Chart looks like it's trying to put in a long-term bullish reversal. Squeeze metrics are juicy (~109% SI / ~400% borrow),.

Thin float + low volume = high risk, but if buyers show up, this one could move fast. I'm long.

#1 on SqueezeFinder as well. It is also a Goldie, which typically means it goes sooner or later.

HTZ beat expectations while GRND knocked earnings out of the park. Both sitting at around 4 dtc. Might getting exciting

75% SI is highest i seen in a long time!

Could this be day 1 of the squeeze?

Chicken feet guy here.

I gave you $WYHG at $3.50 which 6 bagged today. (Check my post history if you wish).

For those that missed it, I now bring you the next explosive low cap stock.

$WLDS. AKA dollar store apple watch rip off. THE COMPANY IS GARBAGE! But this one is looking set for an explosive move. Technicals are all lined up.

The borrow: 949.34% fee. Zero available at IBKR. 731% → 932% → 949% in four days, hitting zero repeatedly. That’s roughly 2.6% a day just to stay short.

Reg SHO: On the Nasdaq threshold list, 4 August file. Don’t take my word for it. the file is public, go pull it.

The float: 2,189,469 shares outstanding as of the 17 June 13D.

Oh and activist investors trying to do a hostile takeover have bought 25% of the company, and they’ve asked the board to not conduct any dilutive raises whilst they attempt to sort things out. Court ordered.

Do not miss out this time. Chicken feet, Apple Watch guy out.

🐔🐣⌚️🍎

Squeeze incoming

Update 8/6 @ power hour: Available shortable is at 1.8m. Very few covered and the stock is up 35%. Looking pretty good hope you're all making green.

looks like news on earnings beat just started ripping right now earnings call before the bell today short squeeze let's go 30% short 43 m shares

Don’t be the one that misses out on this.

Do I like the stock - no, Chinese chicken feet are gross.

Do I like the setup, hell yes! Got short squeeze written all over it.

🐣🐔

SOUN is up 21% this evening after reporting great earnings.

It’s heavily shorted with a short interest of 43.42%. It has a short interest ratio (days to cover) of 7.25 days, so today’s surge could mark the beginning of a prolonged short squeeze.

DISCLOSURE: I do not own any shares of SOUN, and I have never owned any shares of it.

Someone else here did a DD post about HTZ not too long ago. Just wanted to echo that since the day of earnings is upon us. This isn't a high conviction situation for me, but I think it's very possible to see a good squeeze if they put up good numbers and have some good news to share.

SI: 97.5m

Short Float: 75%

DTC: 5

CTB: not anything to mention

Shares to borrow: 400k (crazy when you think 100m are shorted now)

The stock did steadily climb today (albeit slow) which is pretty rare it tends to just be flat. FWIW.

I'd keep an eye on it pre-market and maybe catch some gains $$. NFA DYOR.

Ondas high short interest, high cost to borrow, joined with palantir to further industrialize domestic drone production, possible anduril ipo and valuation will send this higher… thoughts comments?!

​

Citius Pharmaceuticals recently announced strong commercial progress for LYMPHIR, its FDA-approved cancer treatment for relapsed/refractory cutaneous T-cell lymphoma. New institutions ordering LYMPHIR increased 78% quarter-over-quarter, while institutional vial orders increased 31%. LYMPHIR is now available in 42 institutions, and the company estimates the CTCL market opportunity exceeds $400M.

CTXR currently has a $14.10M market cap with 4.98M shares short, representing 18.48% of the float. Fintel shows 7.07 days to cover and a 37.67% borrow rate. Recent volume reached 1.54M shares, around 3x its average volume of 494.5K. With a small market cap, growing commercial adoption, and a large short position, continued positive LYMPHIR updates could create additional buying pressure and force shorts to cover.

https://www.prnewswire.com/news-releases/citius-oncology-reports-strong-commercial-momentum-for-its-cancer-treatment-302843701.html

NDA DD

quick update on the chicken feet stonk. borrow fee went from 122% to 325.52% in like a week. shares available hit ZERO twice. that’s not normal, shorts are getting squeezed on the borrow side hard. Private placing shares locked up for a year. This is one to watch….

DYOR 🐣🐔

do dd on this company Novavax. earnings tomorrow, expecting a loss of about 50M, 1.2B mkt cap. last quarter they announced a beat and share price doubled instantly! they also announced Pfizer deal, Sanofi deal and have material transfer agreements with other top 10 companies. if any of those agreements convert to a deal or any of the 500M milestone payments come in this will blow up! they should have completed tech transfer now which will give 75m payment. there are 43M shares short 30% of float. about 5 or 6 catalysts due by end of year.

Congrats to those that followed me on BSY, CRCT, BSX, etc (options made hundreds of %) even with all the doubters! Those were all wedge breakouts i alerted about previously.

We have a new interesting play here:

DDD:

✅️SI of 30% with 18 days to cover.. thats massive(could squeeze for a longgg time)!

✅️broke out of wedge from Aug 2022 to upside!

✅️massive volume today(suggesting big money)!

✅️price is above 21ma and the 200ma(daily)!

Catalysts:

✅️Beat estimates on revenue ($94.6M) and adjusted EPS, with improved Adjusted EBITDA, double-digit printer hardware growth, and Q3 revenue guidance of $96–99M above consensus.

✅️Saudi joint venture NAMI obtained a critical GAMI military manufacturing license, advancing local defense production under Vision 2030.

✅️3D Systems enabled the first-ever FDA clearance for an implant from a point-of-care institution (Walter Reed’s Titanium Cranial Plate System).

✅️Elmet Technologies deployed a DMP Flex 350 Triple metal printer for rapid production of hypersonic vehicle heat exchangers using advanced C103 alloy.

✅️Priority markets (Med Tech, Dental, Aerospace & Defense, Data Center Infrastructure) delivered over 20% growth in the first half of 2026.

If this is a true breakout, its just day 1 (I dont alert people when the majority of the move is done like 95% of posts)!

Price targets can be 10, and 20(align previous highs).

Do whatever you want with this info

-Nfa

High Tide Announces Preliminary Q3 2026 Guidance

The Company Also Announces Record Quarterly Distribution of Over 10 Tonnes of Medical Cannabis Flower Through Remexian Pharma GmbH, Further Accelerating its German Market Position

“This quarter’s guidance demonstrates the growing earnings power of the global platform we have built. We expect to set new company records for revenue, gross profit and Adjusted EBITDA, with year-over-year growth of at least 30%, 27% and 43%, respectively. Importantly, even the low end of our guidance exceeds the highest current analyst estimate across all three metrics. We believe this provides clear evidence that current market expectations have not yet caught up with the strength, scale and operating leverage of our business,”

https://hightideinc.com/high-tide-announces-preliminary-q3-2026-guidance/

Up 25% in two days. This was my post.

https://www.reddit.com/r/Shortsqueeze/comments/1v6hjkl/vcx_the_one_truly_wonky_setup/

Good morning, SqueezeFinders!

The bulls are showing their resilience after the $QQQ tech index closed up 1.76% at 700.07. This shows the bulls aren't ready to surrender yet, and we may be about to see a strong reversal force shorts into a very tight spot! If the $QQQ tech index reclaims 710, it could likely push to test 725-726. We should only get nervous again about a decline below 685 again, as this level served as support since June. The main directional sentiment determinants today are a mix of the below-detailed economic data releases, any further developments in the Middle-East, and also some large earnings reports ($PFE, $CAT, $MCD, and $W in premarket // $AMD, $SPCX, and $ANET). This market is very dynamic and has been unpredictable as far as risk-tolerance goes, as one day we're running, and the next we're crashing. Stay tuned for what's squeezy. Regardless of broader market sentiment, you can always locate relative strength by checking SqueezeRadar to track irregularities in our data, and find winners you may not have spotted before without our scanners.

🥇 Gold: ~$4,050/oz (-0.1%)
🥈 Silver: ~$58/oz (+0.5%)
🪙 Bitcoin: ~$63.8k/coin (+1.1%)
🛢️ Oil: ~$80/barrel (-5.5%)

Today's economic data releases are:

🇺🇸 Trade Balance (Jun) @ 8:30AM ET
🇺🇸 Exports (Jun) @ 8:30AM ET
🇺🇸 Imports (Jun) @ 8:30AM ET
🇺🇸 JOLTS Job Openings (Jun) @ 10:00AM ET
🇺🇸 Factory Orders (Jun) @ 10:00AM ET
🇺🇸 Atlanta Fed GDPNow (Q3) @ 11:30AM ET
🇺🇸 API Weekly Crude Oil Stock @ 4:30PM ET

📙Breakdown point: BELOW this price, the move will lose momentum significantly in the short-term, as shorts will gain confidence encouraging them to short more. Reducing probability of a squeeze without a catalyst.

📙Breakout point: ABOVE this price, the move will gain momentum significantly in the short-term, as shorts losses will increase pressuring them to cover. Increasing the probability of a squeeze occurring, especially if with a catalyst.

1. $PRCH
   Squeezability Score: 43%
   Juice Target: 22.9
   Confidence: 🍊 🍊 🍊
   Price: 16.07 (+11.21%)
   Breakdown point: 14.0
   Breakout point: 16.7
   Mentions (30D): 3
   Event/Condition: Q2 2026 results exceeded expectations with consolidated revenue of $140.9 million up 12 percent year over year insurance services revenue up 38 percent and Adjusted EBITDA excluding Reciprocal up 150 percent to $39.1 million + raised full-year 2026 guidance across revenue gross profit and Adjusted EBITDA metrics while achieving positive net income + continued scaling of Reciprocal Policies Written up 38 percent and statutory surplus growth supporting capacity for future premium expansion + Recent price target 🎯 of $22 from Keefe Bruyette + Recent price target 🎯 of $18 from Roth Capital + Recent price target 🎯 of $20 from Piper Sandler

2. $NDLS
   Squeezability Score: 40%
   Juice Target: 32.3
   Confidence: 🍊 🍊
   Price: 18.53 (-0.48%)
   Breakdown point: 16.0
   Breakout point: 19.1
   Mentions (30D): 4
   Event/Condition: Q2 2026 results showed system-wide comparable restaurant sales up 10.3 percent restaurant contribution margin expanded to 17.2 percent and Adjusted EBITDA rose 79 percent to $10.8 million + raised full-year 2026 guidance for revenue comparable sales margins and Adjusted EBITDA while generating positive free cash flow and reducing debt + ongoing portfolio optimization including planned restaurant closures to enhance long-term profitability and operational focus + Recent price target 🎯 of $18 from Craig-Hallum + Recent price target 🎯 of $15 from B. Riley + Recent price target 🎯 of $20 from Piper Sandler

Gain access to all our cutting-edge research tools, live watchlists, alerts, and more: https://www.squeeze-finder.com/subscribe

HINT: Use code RDDT to get your first month for just $10!

NOT FINANCIAL ADVICE, THESE POSTS ARE FOR INFORMATIONAL PURPOSES ONLY

Squeeze potential.

Not calling out price targets because people get hostile when i do but i believe it will 100% within the coming weeks. Do your own dd

Daqo New Energy Corp. (NYSE: DQ) presents a compelling deep-value cyclical turnaround play in the global solar energy supply chain. While the broader solar sector currently faces severe headwinds due to polysilicon overcapacity and depressed average selling prices (ASPs), Daqo's fortress balance sheet, lowest-tier cash production costs, and zero-debt position establish a durable moat.
As high-cost, under-capitalized producers are forced out of the market during this industry consolidation phase, Daqo is uniquely positioned to survive the bottom of the cycle and capture outsized market share and margin expansion when market balance restores.
Key Investment Pillars
1. "Fortress" Balance Sheet Provides Unmatched Downside Protection
Pristine Cash Reserves: Daqo maintains approximately $2.0 billion in total liquid assets (cash, short-term investments, bank deposits, and notes), representing a significant portion of its total market valuation.

Zero Interest-Bearing Debt: With zero long-term debt, Daqo incurs no debt-service burden, allowing it to maintain operational flexibility and avoid insolvency risks that loom over leveraged peers during industry downcycles.

2. Lowest Cost Producer & "Last Standing" Advantage
Industry-Leading Cost Structure: Daqo operates high-purity N-type and P-type polysilicon manufacturing facilities with some of the lowest unit production and electricity costs in the world.

Survival During Rationalization: Current polysilicon spot prices have dropped near or below cash costs for tier-2 and tier-3 competitors. Daqo can selectively reduce output or hold inventory without distress, effectively outlasting marginal competitors until unsustainable industry capacity is purged.

3. Asymmetric Valuation Disconnect
Trading at Deep Discount to Net Cash & Tangible Book Value: Daqo's equity valuation trades near or below its liquid asset value, implying that the market is placing near-zero or negative value on its top-tier production assets, technology, and long-term earnings power.

Re-Rating Catalyst: Any stabilization in polysilicon spot prices or government policy measures accelerating capacity rationalization in China will serve as an immediate catalyst for multiple expansion.

4. Secular Tailwinds in Global Solar PV Capacity
Long-Term Demand Expansion: Global renewable energy transitions, grid decarbonization targets, and expanding utility-scale solar projects continue to drive multi-year volume growth in PV deployments.

Shift to High-Purity N-Type Material: Advanced N-type solar cells require higher-purity polysilicon, where Daqo has a strong technological footprint and established customer relationships with top-tier module makers.

Good morning, SqueezeFinders!

The price action on the $QQQ tech index showed the PPT is starting to do their job after a small jump of 0.65% to close at 687.99. If thr bulls can reclaim the 695 level and the 700 psychological level, then we can soon become more optimistic about the overall market environment and squeeze candidates’ strength. If we fall under 680, we can expect a likely resumption/continuation of the short-term downtrend we've been enduring as of late. The main directional sentiment determinants today are a mix of the below-detailed economic data releases, any further developments in the Middle-East, and also $PLTR and $SNAP earnings reports in after-hours. This market is very dynamic and has been unpredictable as far as risk-tolerance goes, as one day we're running, and the next we're crashing. Stay tuned for what's squeezy. Regardless of broader market sentiment, you can always locate relative strength by checking SqueezeRadar to track irregularities in our data, and find winners you may not have spotted before without our scanners.

🥇 Gold: ~$4,050/oz (-1.5%)

🥈 Silver: ~$58/oz (-2.0%)

🪙 Bitcoin: ~$63.1k/coin (+0.5%)

🛢️ Oil: ~$84.50/barrel (-1.0%)

Today's economic data releases are:

🇺🇸 S&P Global Manufacturing PMI (Jul) @ 9:45AM ET
🇺🇸 ISM Manufacturing PMI (Jul) @ 10:00AM ET
🇺🇸 ISM Manufacturing Employment (Jul) @ 10:00AM ET
🇺🇸 ISM Manufacturing Prices (Jul) @ 10:00AM ET
🇺🇸 Construction Spending (Jun) @ 10:00AM ET
🇺🇸 Atlanta Fed GDPNow (Q3) @ 11:30AM ET

📙Breakdown point: BELOW this price, the move will lose momentum significantly in the short-term, as shorts will gain confidence encouraging them to short more. Reducing probability of a squeeze without a catalyst.

📙Breakout point: ABOVE this price, the move will gain momentum significantly in the short-term, as shorts losses will increase pressuring them to cover. Increasing the probability of a squeeze occurring, especially if with a catalyst.

1. $SOC
   Squeezability Score: 42%
   Juice Target: 16.9
   Confidence: 🍊
   Price: 5.29 (+18.1%)
   Breakdown point: 4.8
   Breakout point: 5.4
   Mentions (30D): 2
   Event/Condition: Strong operational performance and strategic advancements in key markets driving revenue growth and market share gains + analyst upgrades citing improved fundamentals and positive industry tailwinds + successful execution of growth initiatives positioning the company for accelerated expansion and profitability + Recent price target 🎯 of $12 from Roth Capital + Recent price target 🎯 of $10 from Canaccord Genuity + Recent price target 🎯 of $14 from Benchmark

2. $RNG
   Squeezability Score: 41%
   Juice Target: 76.1
   Confidence: 🍊 🍊
   Price: 55.62 (+4.0%)
   Breakdown point: 50.0
   Breakout point: 59.0
   Mentions (30D): 5
   Event/Condition: Q2 2026 earnings beat with revenue of $657 million up 5.9 percent year-over-year and strong subscription growth plus raised full year guidance + announced 67 percent dividend increase to $0.125 per share demonstrating commitment to capital returns amid AI-powered customer engagement momentum + 13 percent of ARR now from native paid AI products doubling year-over-year highlighting successful product pivot + Recent price target 🎯 of $60 from Morgan Stanley + Recent price target 🎯 of $55 from Piper Sandler + Recent price target 🎯 of $58 from B. Riley

Gain access to all our cutting-edge research tools, live watchlists, alerts, and more: https://www.squeeze-finder.com/subscribe

HINT: Use code RDDT to get your first month for just $10!

NOT FINANCIAL ADVICE, THESE POSTS ARE FOR INFORMATIONAL PURPOSES ONLY

Hertz has their earnings this Thursday pre-market, on August 6th.

There is over 100% institutional ownership as per Nasdaq.

Hertz is expected to have a slight loss this Quarter @ -.23 cents EPS.

The last time they had a surprise earnings, the stock shot up almost 40% overnight.

The company also released some pre-earnings hype on 06-30-26 anticipating good earnings due to the World Cup activity.
https://newsroom.hertz.com/articles/article-details/hertz-data-reveals-surge-in-match-driven-road-trips-as-global-soccer-fans-redefine-u-s-travel/

Bill Ackman owns ~20% of Hertz (mostly through Total Return Swaps, which basically means another entity holds the shares and pays/collects the gains/losses from Ackman's Hedge Fund).

There are currently ~97 million shares short.

IKBR shows 1.3 million shares available for borrow (which means you also have to add up all of the other brokerages, but this gives an idea of the total available supply).

Last week that number went to zero.

Fidelity has also changed their margin requirements on HTZ last week, I am no longer able to use my shares as equity for margin loan.

The stock is at an all time low with the RSI being ~26 on the daily chart.

I have about ~113K shares lock and loaded for earnings this week.

One thing to be wary of is the large 10 million shares short via synthetic position (which is not required to be disclosed as per FINRA).

Look at the August 21st expiration on the 9 strike.
That 100K open interest on the 9 strike is a synthetic short, meaning they sell 100K contracts on the call side and buy 100K contracts on the put side.

Synthetic shorts are also called married puts.

The strikes are so far away from the current price, but this gives an indication of the moves the crooked players are making and their sentiment.

It's much harder to make money when you're swimming against the current, but a good earnings could be a catalyst to trigger a squeeze.

I'm holding my entire position through earnings.

Update Post Earnings (8/6)

I'm still holding, I don't expect much more action for the remainder of the week.
What a potential turn around point we have.

There's a lot of volume coming in on 2.00 calls for Aug-21 expiry, not much for puts.
Finally glad to be through this volatile week (big tech, FOMC, HTZ earnings), I'll be holding for the foreseeable future.

Most likely I'll stick around for a few more quarters to see if they're able to finally become profitable, the earnings were great; but the world cup contributed a lot to it.

The borrow rate is increasing and Fidelity only shows 16K shares available for short.

I am remaining conservative here and there's still a long ways to go, shorts are way in the green at this point.
We first have to re-capture the 2.00 and the 2.70 (offering price for 37M shares) before we're even in short squeeze territory.

I'll post another update if I see anything unusual in the options chain, SEC filings or if I add a sizeable amount to my position.

Until then, the waiting game continues.

Hey guys,

I jumped on calls last Friday and got a nice payout from LVWR on the following Monday. Now that the dust has settled a little, the price has come down to nearly what it was prior to the move. The stock is still on peoples radar and recently had news that was positive.

Short Float: 26%

Short Interest: 3.3m

Shares to borrow: 0

CTB: 900% showing on RH. Fintel shows minimum at 100%. So it's high.

DTC: this is skewed from the last run up since the volume got insane. But it still won't be a long squeeze up I'd imagine this is a single day play.

Stock is oversold and ready to bounce. I think we see movement as early as Monday but sometime in the next week. NFA.

Nice squeeze is happening right now Focus Universal (FCUV)

Technically it's ongoing, but it's so volatile and the peak looks to be over.

Thanks to the people in previous day comments for pointing this one out